3171 results for «291»
3171 results
EAPCI Fellows Course - Opening
15 May 2017 – From EuroPCR 2017
Welcome to the European Interventional Cardiology Fellows Course - Opening, consult this session if you want to find out more about the course hosted by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on Monday 15 and Tuesday morning 16 May.
These presentations were part of the EAPCI...
AsiaPCR/SingLIVE 2018: Closing Ceremony and Awards
27 Jan 2018 – From AsiaPCR/SingLIVE 2018
Join U. Kaul, T.H. Koh and S.T. Lim for the AsiaPCR/SingLIVE 2018 Closing Ceremony if you want to find out who this year's Best Abstract and Best Clinical case award winners are?
Opening ceremony
08 Apr 2017 – From PCR Tokyo Valves 2017
Closing Ceremony and Awards
09 Apr 2017 – From PCR Tokyo Valves 2017
PCR London Valves 2017 Opening Ceremony - Welcome address
25 Sep 2017 – From PCR London Valves 2017
Welcome to Imaging Day
24 Sep 2017 – From PCR London Valves 2017
Welcome and introduction to PCR Innovators Day London
24 Sep 2017 – From PCR Innovators Day 2017
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events
01 Sep 2022
Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.
Author
Comparison of puncture success rate between distal radial access and transradial access in patients with ST-elevation myocardial infarction (DRAMI)
07 Nov 2024
Aaysha Cader provides her take on the DRAMI trial presented by Jun-Won Lee at TCT 2024 in Washington.
Author
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial
05 Mar 2023
Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
